Abbott Laboratories (ABT) Cost of Revenue (2009 - 2026)
Abbott Laboratories (ABT) posted Cost of Revenue of $5.3 billion for Q2 2026, up 8.9% sequentially from $4.9 billion in Q1 2026, and up 9.7% YoY from $4.9 billion in Q2 2025.
Abbott Laboratories (ABT) Cost of Revenue (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Cost of Revenue for 18 years, with the latest figure at $5.3 billion in Q2 2026.
- Quarterly Cost of Revenue rose 9.7% year-over-year to $5.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $20.2 billion (up 6.59% YoY) and the FY2025 annual result came in at $19.3 billion, up 3.28% from the prior year.
- Cost of Revenue grew to $5.3 billion in Q2 2026 per ABT's latest filing, from $4.9 billion in the prior quarter.
- Over five years, Cost of Revenue peaked at $5.3 billion in Q2 2026 and troughed at $4.3 billion in Q1 2023.
- A 5-year average of $4.7 billion and a median of $4.7 billion in 2022 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue advanced 13.32% in 2022, then slipped 13.15% in 2023.
- Over 5 years, Cost of Revenue stood at $4.6 billion in 2022, then decreased by 0.81% to $4.6 billion in 2023, then increased by 8.47% to $4.9 billion in 2024, then fell by 0.4% to $4.9 billion in 2025, then increased by 8.19% to $5.3 billion in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $5.3 billion, $4.9 billion, and $4.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 635.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.33 Bn |
| Jun 30, 2026 | 5.33 Bn |
| Mar 31, 2026 | 4.89 Bn |
| Mar 31, 2026 | 4.89 Bn |
| Dec 31, 2025 | 4.92 Bn |
| Dec 31, 2025 | 4.92 Bn |
| Sep 30, 2025 | 5.08 Bn |
| Sep 30, 2025 | 5.08 Bn |
| Jun 30, 2025 | 4.85 Bn |
| Jun 30, 2025 | 4.85 Bn |
| Mar 31, 2025 | 4.47 Bn |
| Mar 31, 2025 | 4.47 Bn |
| Dec 31, 2024 | 4.94 Bn |
| Dec 31, 2024 | 4.94 Bn |
| Sep 30, 2024 | 4.70 Bn |
| Sep 30, 2024 | 4.70 Bn |
| Jun 30, 2024 | 4.60 Bn |
| Jun 30, 2024 | 4.60 Bn |
| Mar 31, 2024 | 4.46 Bn |
| Mar 31, 2024 | 4.46 Bn |